Alice Di Rocco | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Bing-Neel syndrome coexisting with oligodendroglioma	LEUKEMIA & LYMPHOMA	2022
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL)	LEUKEMIA & LYMPHOMA	2022
Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis	LEUKEMIA & LYMPHOMA	2022
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases	HEMATOLOGICAL ONCOLOGY	2022
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)	HEMATOLOGICAL ONCOLOGY	2022
Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment	CANCERS	2022
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study	HEMATOLOGICAL ONCOLOGY	2022
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study	BLOOD	2022
Use of a maturity model for facilitating the introduction of CAR T-cell therapy-Results of the START CAR-T project	GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT	2022
Utility of Flow Cytometry Ascitic Fluid Analysis for Rapid Diagnosis of B-Cell Peritoneal Lymphomatosis	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2022
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics	BRITISH JOURNAL OF HAEMATOLOGY	2022
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial	BRITISH JOURNAL OF HAEMATOLOGY	2022
Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy	EXPERT REVIEW OF HEMATOLOGY	2022
Semen quality in non-Hodgkin lymphoma survivors: a monocentric retrospective study	HUMAN REPRODUCTION	2021
Relapsed/Refractory Multiple Myeloma Patients. A Multicenter Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy	BLOOD	2021
Clinical utility and physician perceptions of a digital platform for electronic patient-reported outcomes monitoring in patients with hematologic malignancies in real-world practice.	BLOOD	2021
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial	THE LANCET. HAEMATOLOGY	2021
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi	JOURNAL OF CLINICAL ONCOLOGY	2021
CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)	FRONTIERS IN ONCOLOGY	2021
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology	SCIENTIFIC REPORTS	2021

Progetti di Ricerca

The impact of different treatment strategies on minimal residual disease (MRD) in young and elderly Mantle cell lymphoma (MCL) patients.
Non invasive monitoring of aggressive lymphomas by next generation sequencing/droplet digital PCR on circulating tumor-DNA (ct-DNA)